UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (date of earliest event reported): July 1, 2009
CEL-SCI CORPORATION
----------------------------------------------------------------
(Exact name of Registrant as specified in its charter)
Colorado 0-11503 84-0916344
-------------------- ------------------------ ------------------------
(State or other jurisdiction (Commission File No.) (IRS Employer
of incorporation) Identification No.)
8229 Boone Boulevard, Suite 802
Vienna, Virginia 22182
--------------------------------------------------------
(Address of principal executive offices, including Zip Code)
Registrant's telephone number, including area code: (703) 506-9460
--------------
N/A
--------------------------------------------
(Former name or former address if changed since last report)
Item 1.01 Entry Into a Material Definitive Agreement
On July 1, 2009 CEL-SCI Corporation sold 486,244 shares of its common stock
to a group of private investors for $194,497 or $0.40 per share. The investors
also received warrants which entitle the investors to purchase 325,783 shares of
CEL-SCI's common stock. The warrants may be exercised at any time on or after
December 24, 2009 and on or prior to December 24, 2014 at a price of $0.50 per
share.
CEL-SCI has filed with the Securities and Exchange Commission a prospectus
supplement to its shelf Registration Statement on Form S-3 registering the
shares of common stock and warrants sold to the private investors.
Item 9.01 Financial Statements and Exhibits
Exhibit Number Description
-------------- -----------
10(j) Securities Purchase Agreement
10(k) Form of Warrant
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Date: July 2, 2009.
CEL-SCI CORPORATION
By: /s/ Geert R. Kersten
---------------------------------
Geert R. Kersten, Chief Executive
Officer
3
CEL-SCI CORPORATION
FORM 8-K
EXHIBITS